193

Last update : 09/05/2017

HCC - Hepatocellular Carcinoma

Head : Stücker Isabelle

Main objective

To evaluate the role of UDP-glucuronosyltransferase enzymes in hepatocellular carcinoma.

Inclusion criteria

- Men - adult - below 75 years of age - born in Europe

Last update : 09/05/2017

ENDOCARDITIS - Repeated cross-sectional study for patients with infective endocarditis: surgical impact

Head : Alla Francois, CIC-EC INSERM CHU
Hoen Bruno, INFECTIOLOGIE CHU
Duval Xavier, CIC

Version 1

194

Last update : 01/01/2018

ENDOCARDITIS - Repeated cross-sectional study for patients with infective endocarditis: surgical impact

Head : Alla Francois, CIC-EC INSERM CHU
Hoen Bruno, INFECTIOLOGIE CHU
Duval Xavier, CIC

Main objective

To assess the impact of surgical strategy on medium to long-term morbidity and mortality.
Secondary objective: descriptive and analytic.

Inclusion criteria

Patients over 18 years of age treated in hospital for definite (Duke) infective endocarditis (IE) in 2008.

Last update : 01/01/2018

- Survey on The Health of Children Attending Primary Schools in The Provence-Alpes-Côte d'Azur (PACA) Region

Head : Kovess-Masfety Viviane, INSERM U705 et U669

Version 1

195

Last update : 09/05/2017

- Survey on The Health of Children Attending Primary Schools in The Provence-Alpes-Côte d'Azur (PACA) Region

Head : Kovess-Masfety Viviane, INSERM U705 et U669

Main objective

1) To assess the prevalence of most the common mental health issues (with teachers and children) and physical issues (with parents) for primary school children. 2) to assess the principle social and psychological risk factors for mental health among young people (with parents). 3) To assess the use of health services (with parents).

Inclusion criteria

Children attending private or public primary schools in Aix-Marseille and Nice.

Last update : 09/05/2017

DOREMI - Factors influencing the motivation of the unbalanced type-2 diabetic obese patient in monotherapy by oral diabetes medication

Head : VIGNAL Franck, Sanofi Aventis

Version 1

196

Last update : 01/01/2018

DOREMI - Factors influencing the motivation of the unbalanced type-2 diabetic obese patient in monotherapy by oral diabetes medication

Head : VIGNAL Franck, Sanofi Aventis

Main objective

Describe the factors influencing the motivation of the unbalanced type-2 diabetic obese patient in monotherapy by oral diabetes medication in adhering to the drug and hygiene and dietary care of its cardiometabolic risk factors.

Inclusion criteria

Man or woman over the age of 18 years, Type-2 diabetes treated via oral diabetes medication monotherapy, Having a HbA1c rate ≥ 6.5%, A BMI ≥ 30 kg/m2, An abdominal obesity defined according to the NCEP/ATPIII criteria: Waist > 88 cm for women and > 102 cm for men,
Able to understand simple recommendations in terms of physical activity and complete a self-evaluation questionnaire

Last update : 01/01/2018

D.E.S.IR. - Epidemiological data about insulin resistance syndrome

Head : Balkau Beverley, U1018 Centre de Recherche en Epidémiologie et santé des Populations (CESP)

Version 3

197

Last update : 01/01/2020

D.E.S.IR. - Epidemiological data about insulin resistance syndrome

Head : Balkau Beverley, U1018 Centre de Recherche en Epidémiologie et santé des Populations (CESP)

Main objective

Describe natural history of insulin resistance syndrome and its consequences.
Evaluate diabetes risk factors.

Inclusion criteria

Men and women, aged between 30 and 65, consulting in the examination centers

Last update : 01/01/2020

méMOTS - Évaluation des fonctions cognitives des enfants ayant un déficit en hormone de croissance et des enfants nés petits pour l'âge gestationnel

Head : Troy Sylvie, Pfizer

Version 1

198

Last update : 01/01/2020

méMOTS - Évaluation des fonctions cognitives des enfants ayant un déficit en hormone de croissance et des enfants nés petits pour l'âge gestationnel

Head : Troy Sylvie, Pfizer

Main objective

Evaluate the level of verbal and non-verbal cognitive functions of children with a growth hormone deficiency (GHD) and children born small for the fertilization age before beginning a GH treatment.
- Evaluate the percentage of GHD children and the percentage of SGA children with language cognitive function disorders.
- Evaluate the percentage of GHD children and the percentage of SGA children with non-verbal cognitive function disorders.
- Compare the average level of the language and non-verbal cognitive functions of GHD and SGA children to a reference population of French children.
- Compare the level of verbal and non-verbal cognitive functions of GHD children and of SGA children.

Inclusion criteria

Child between the ages of 4 to 9 years,
- Understanding French,
- For whom the GH treatment was approved by a health insurance fund,
- With an adequate supplementation of the other pituitary deficiencies in the case of a multiple deficiency.

Last update : 01/01/2020